Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 58.23
+3.05 (5.53%)
At close: Jul 31, 2026
SHE:301093 Market Cap
SHE:301093 has a market cap or net worth of 12.42 billion as of July 31, 2026. Its market cap has increased by 190.75% in one year.
Market Cap
12.42B
Enterprise Value
11.33B
Revenue
603.43M
Ranking
n/a
PE Ratio
287.02
Stock Price
58.23
ChartMarket Cap Chart
Since November 1, 2021, SHE:301093's market cap has increased from 7.03B to 12.42B, an increase of 76.65%. That is a compound annual growth rate of 12.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 12.42B | 50.78% |
| Dec 31, 2025 | 8.24B | 178.70% |
| Dec 31, 2024 | 2.96B | -32.51% |
| Dec 29, 2023 | 4.38B | 28.05% |
| Dec 30, 2022 | 3.42B | -51.34% |
| Dec 31, 2021 | 7.03B | -0.04% |
| Nov 1, 2021 | 7.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhende Medical | 24.00B |
| Winner Medical | 17.86B |
| Shenyang Xingqi Pharmaceutical | 15.18B |
| Micro-Tech (Nanjing) Co.,Ltd | 13.60B |
| Autek China | 10.27B |
| Tofflon Science and Technology Group | 9.27B |
| Sansure Biotech | 8.88B |
| Qingdao NovelBeam Technology | 8.10B |